In CD4+ T cells from SLE patients or lupus-prone mice, activation of the mTOR signaling pathway drives enhanced glycolysis, which promotes the differentiation of CD4+ T cells into pathogenic Th17 cells while compromising the immunosuppressive function of Treg cells (11, 97–100). Here, MTOR is linked to systemic lupus erythematosus.